Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett R Beno

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virusXiaofan Zheng, Thomas W Hudyma, Scott W Martin, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral ActivityAlicia Regueiro-Ren, Zheng Liu, Yan Chen, et al.
Medchemcomm|August 16, 2018
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymeraseKyle J Eastman, Kyle Parcella, Kap-Sun Yeung, et al.
Journal of Medicinal Chemistry|August 2, 2018
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)Alicia Regueiro-Ren, Jacob J Swidorski, Zheng Liu, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding SiteShiva Krishna Reddy Guduru, John P Caldwell, Katherine M Digianantonio, et al.
Journal of Medicinal Chemistry|April 22, 2017
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap-Sun Yeung, Brett R Beno, Kyle Parcella, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|April 14, 2011
Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virusXiaofan Zheng, Thomas W Hudyma, Scott W Martin, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral ActivityAlicia Regueiro-Ren, Zheng Liu, Yan Chen, et al.
Medchemcomm|August 16, 2018
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymeraseKyle J Eastman, Kyle Parcella, Kap-Sun Yeung, et al.
Journal of Medicinal Chemistry|August 2, 2018
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)Alicia Regueiro-Ren, Jacob J Swidorski, Zheng Liu, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding SiteShiva Krishna Reddy Guduru, John P Caldwell, Katherine M Digianantonio, et al.
Journal of Medicinal Chemistry|April 22, 2017
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap-Sun Yeung, Brett R Beno, Kyle Parcella, et al.
Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.
Pageof 4